Literature DB >> 15923516

Spare the rod and spoil the eye.

G B Arden1, R L Sidman, W Arap, R O Schlingemann.   

Abstract

This review presents a new unified view of the pathogenesis of three common causes of acquired retinal degenerative disease-diabetic retinopathy, age related macular degeneration, and retinopathy of prematurity. In these three conditions, angiogenesis has a predominant role in the development of sight threatening pathology. Angiogenesis is controlled by among other factors the expression of vascular endothelial growth factor (VEGF), which in turn is regulated by absolute and relative lack of oxygen. The severe pathological manifestations of these three conditions are not part of a general underlying disease process because they are peculiar to the eye, and the profound hypoxia that develops in normal retina during dark adaptation (rod driven hypoxia) is an adequate and elegant additional factor to explain their pathogenesis. A large number of experimental reports support this conclusion, although rod driven anoxia is not generally considered as a causal factor in ocular disease. However, the hypothesis can be critically tested, and also suggests novel methods of treatment and prevention of these conditions that may be simpler and more inexpensive than current therapies and that have a smaller potential for adverse effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923516      PMCID: PMC1772679          DOI: 10.1136/bjo.2004.062547

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  93 in total

1.  Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes.

Authors:  H Sone; Y Kawakami; Y Okuda; Y Sekine; S Honmura; K Matsuo; T Segawa; H Suzuki; K Yamashita
Journal:  Diabetologia       Date:  1997-06       Impact factor: 10.122

2.  Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects.

Authors:  F M Dean; G B Arden; A Dornhorst
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  I. Impaired dark adaptation in symptomatic carotid artery disease.

Authors:  U Havelius; D Bergqvist; P Falke; B Hindfelt; T Krakau
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

4.  II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra?

Authors:  U Havelius; D Bergqvist; B Hindfelt; T Krakau
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

5.  Sun exposure and age-related macular degeneration. An Australian case-control study.

Authors:  P Darzins; P Mitchell; R F Heller
Journal:  Ophthalmology       Date:  1997-05       Impact factor: 12.079

6.  Laser treatment in subjects with high-risk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function.

Authors:  R H Guymer; M Gross-Jendroska; S L Owens; A C Bird; F W Fitzke
Journal:  Arch Ophthalmol       Date:  1997-05

7.  Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.

Authors:  H P Hammes; J Lin; R G Bretzel; M Brownlee; G Breier
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

8.  Advanced glycation end products increase retinal vascular endothelial growth factor expression.

Authors:  M Lu; M Kuroki; S Amano; M Tolentino; K Keough; I Kim; R Bucala; A P Adamis
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

9.  Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation.

Authors:  C M Sue; P Mitchell; D S Crimmins; C Moshegov; E Byrne; J G Morris
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

10.  Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications.

Authors:  C Frennesson; S E Nilsson
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more
  52 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

3.  Tomographic imaging of oxygen by phosphorescence lifetime.

Authors:  Sovia V Apreleva; David F Wilson; Sergei A Vinogradov
Journal:  Appl Opt       Date:  2006-11-20       Impact factor: 1.980

Review 4.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

5.  Topographical alterations of inner retinal activity during systemic hyperoxia-hypercapnia in normal subjects and patients with type 1 diabetes.

Authors:  Anne Kurtenbach; Traugott Dietrich; Eberhart Zrenner; Hana Langrová
Journal:  Doc Ophthalmol       Date:  2010-01-23       Impact factor: 2.379

Review 6.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

7.  Oxygen microscopy by two-photon-excited phosphorescence.

Authors:  Olga S Finikova; Artem Y Lebedev; Alexey Aprelev; Thomas Troxler; Feng Gao; Carmen Garnacho; Silvia Muro; Robin M Hochstrasser; Sergei A Vinogradov
Journal:  Chemphyschem       Date:  2008-08-25       Impact factor: 3.102

8.  Active HIF-1 in the normal human retina.

Authors:  John M Hughes; Arjan J Groot; Petra van der Groep; René Sersansie; Marc Vooijs; Paul J van Diest; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

9.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

Review 10.  Spare the rods and spoil the retina: revisited.

Authors:  S Sivaprasad; G Arden
Journal:  Eye (Lond)       Date:  2015-12-11       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.